BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
Follow-Up Questions
What is the price performance of BLLSF stock?
The current price of BLLSF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Biolight Life Sciences Ltd?
Biolight Life Sciences Ltd belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Biolight Life Sciences Ltd market cap?
Biolight Life Sciences Ltd's current market cap is $0
